Released by Sentry BioPharma Services In, as it says, what now appears to be a prescient discussion described in an article written in April, 2020, Tim Gunn wrote about how vaccine cold chain supply practices were soon going to be put to the test to store and distribute COVID-19 vaccines....
Friday, July 23, 2021 | Read More
How Sentry BioPharma Services supports clinical studies with just-in-time custom labeling/kitting/packaging and more. Released by Sentry BioPharma Services Contract Pharma Staff 06.17.21As crucial to innovation as they are, clinical studies come with a unique set of logistical challenges...
Thursday, June 24, 2021 | Read More
How full range of storage environments and services of Sentry BioPharma Services, Inc. (Sentry) save time and money for pharma companies. Released by Sentry BioPharma Services •Contract Pharma Staff• 03.31.21A significant recent trend in the biopharma industry has been an increasing number of...
Monday, May 17, 2021 | Read More
Developing and delivering new drugs and biological products in a highly-regulated industry offers unique challenges to executives, project managers and functional managers alike. Sentry BioPharma Services' experienced team offers a practical and pragmatic approach to collaborate with its pharmaceutical clients to solve complex issues surrounding temperature-sensitive drug management and distribution while safeguarding drug safety, identity, strength, purity and quality (SISPQ). Areas of custom solutions are numerous. A few which Sentry highlights include:
Active pharmaceutical ingredients (APIs) and high-risk biopharmaceutical products share at least one attribute: the probability and impact of loss is manageable. Sentry BioPharma Services applies the same principles implemented across high-risk and high-value products to the management and protection of high-value APIs. Sentry’s experienced team strives to limit the probability and impact of loss, providing unparalleled protection for high-value ingredients. To learn more please visit API Management.
Regulatory oversight shapes every dimension of controlled substances: licensing, registration, storage, security, use, inventory and controlled drug disposal. The DEA licenses Sentry to store, distribute, manage returns, recall and manage destruction of Schedule III-V controlled substances. Sentry BioPharma Services provides the exacting care and management required to safeguard controlled substances which are brought into Sentry’s custody and care. To learn more please visit Controlled Substances.
Sentry's GMP pharmaceutical facility maintains active foreign trade zone (FTZ) status per Foreign Trade Zones Act 19 (U.S. Code Title 19, Chapter 1A). Sentry's active FTZ status and customs bond support import optimization and control of biological and pharmaceutical ingredients, materials, semi-finished and finished drug products.
Interestingly, a FTZ in the United States (US) is not technically considered a part of the US, and the same is true for foreign trade zones in other countries. To learn more please visit Foreign Trade Zone.
Sentry BioPharma Services’ maintains a GSA Logistics Worldwide Supply Schedule Contract, allowing us to respond to the unique logistic challenges of the federal government, while simultaneously providing GMP, best-in-class solutions.
Secure vaccine storage and distribution services protect your inventory throughout the supply chain. Sentry’s guardianship ensures proper vaccine storage, rotation, accurate tracking and proper distribution of vaccines for routine fulfillment or pandemic response. To learn more please visit Vaccine Storage and Distribution.
For more information about how Sentry can implement a custom solution to meet your unique pharmaceutical supply chain challenges, contact Sentry via email or by phone at 1-866-757-7400, for a complimentary, no obligation phone call with one of Sentry's problem-solving experts.